An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)
Clinical trial NCT06126146 · COMPLETED
Trial details
- NCT number
- NCT06126146
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-26
- Primary completion
- 2024-05-16
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.